Insight into ICON's Functional Service Provider Model
Welcome to an insightful exploration of ICON Strategic Solutions (ISS) and their innovative Functional Service Provider (FSP) model. This service offers sponsors a unique way to enhance their operational functionalities in clinical research. Join us as we dive into how ICON surpasses conventional internal recruitment strategies, delivering unparalleled support to clinical research endeavors.
Webinar Highlights on FSP Services
Our upcoming free webinar will shed light on the exceptional advantages ICON offers through its FSP services. Attendees will gain valuable insights into the operational strengths of ICON's methodologies, including how they provide superior oversight and governance for clinical workforce management. By sharing realistic scenarios, our expert speakers will reveal effective ways to address clinical workforce challenges that sponsors face in Korea.
The Challenge of Talent Recruitment
The dynamic landscape of clinical research today brings various recruitment hurdles. As sponsors in Korea strive to attract and retain qualified research professionals, challenges such as limited talent pools, high turnover, and financial constraints complicate the recruitment landscape. It’s essential for these sponsors to ensure they are equipped with the right expertise to meet evolving clinical demands.
Operational Efficiency Through the FSP Model
ICON's FSP model emerges as a beacon of hope amidst these recruitment challenges. By utilizing the FSP service, sponsors can benefit from a ready pool of vetted professionals who seamlessly integrate into existing teams. This model not only maintains operational control for sponsors but also brings in ICON's efficiencies, best practices, and experienced resources, ensuring optimal performance in clinical trials.
Enhancing Resource Flexibility and Retention
The benefits of the FSP model extend beyond mere recruitment; they offer a strategic solution for enhancing resource flexibility. This model significantly reduces the administrative burden on sponsors by introducing structured career development pathways for clinical staff, thereby improving retention rates. Moreover, sponsors gain access to a comprehensive global talent network with specialist therapeutic expertise tailored to meet their specific clinical project needs.
Lessons Learned from ICON's Experience
During this informative session, speakers will share compelling insights from ICON’s extensive experience supporting Korean sponsors. You'll learn about strategies employed to navigate the unique market challenges and the innovative solutions that led to successful outcomes in clinical research. Attendees will finish the session with a clear understanding of how ICON's FSP model can facilitate overcoming recruitment barriers, enhancing resource allocation, and ultimately supporting clinical research goals with increased efficiency.
Join Us for the Webinar
Don’t miss out on the opportunity to learn from industry experts at ICON, including Julian Song as the moderator, alongside Hyunju Park and May Cho, who will provide practical insights during the webinar.
Frequently Asked Questions
What is ICON's FSP model?
ICON's FSP model allows sponsors to augment their clinical development efforts by accessing a dedicated talent pool trained by ICON, while still maintaining operational control.
How does the FSP model improve resource flexibility?
The model provides sponsors with flexible resource options and streamlined management, reducing administrative burdens significantly.
What are the main challenges addressed by ICON?
ICON addresses challenges such as talent recruitment, retention, and recruitment costs, helping sponsors navigate complex clinical research environments.
Who are the speakers at the webinar?
The webinar features Julian Song, Hyunju Park, and May Cho, who all bring valuable insights into operational strategies in clinical research.
Why should I register for this webinar?
Participating in this webinar will equip you with critical strategies and insights essential for optimizing clinical research in the increasingly competitive landscape.
